Ashley Sabus

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 11

Top Topics

Stem Cell Transplantation

Radiation Therapy

Top Venues

Pediatric blood & cancer

Journal of clinical pharmacy and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Cassandra Rush, Ashley Sabus, Zanette Kanani Bradley, Maxwell Herbert, Molly Hemenway
The incidence and characterization of weight gain associated with MEK inhibitors in pediatric patients. Pediatric blood & cancer (2023)
Priya P Chan, Ashley Sabus, Molly S Hemenway, Kathryn C Chatfield, Christina J White, David M Mirsky, Nicholas K Foreman, Nathan A Dahl
Thromboembolic toxicity observed with concurrent trametinib and lenalidomide therapy. Pediatric blood & cancer (2023)
Cassandra Rush, Ashley Sabus, Zanette Kanani Bradley, Maxwell Herbert, Molly Hemenway
The incidence and characterization of weight gain associated with MEK inhibitors in pediatric patients. Pediatric blood & cancer 70 (4) (2023)
Cassandra Rush, Ashley Sabus, Zanette Kanani Bradley, Maxwell Herbert, Molly Hemenway
The incidence and characterization of weight gain associated with MEK inhibitors in pediatric patients. Pediatric blood & cancer 70 (4) (2023)
Priya P Chan, Ashley Sabus, Molly S Hemenway, Kathryn C Chatfield, Christina J White, David M Mirsky, Nicholas K Foreman, Nathan A Dahl
Thromboembolic toxicity observed with concurrent trametinib and lenalidomide therapy. Pediatric blood & cancer 70 (3) (2023)
Priya P Chan, Ashley Sabus, Molly S Hemenway, Kathryn C Chatfield, Christina J White, David M Mirsky, Nicholas K Foreman, Nathan A Dahl
Thromboembolic toxicity observed with concurrent trametinib and lenalidomide therapy. Pediatric blood & cancer 70 (3) (2023)
Cassandra Rush, Ashley Sabus, Zanette Kanani Bradley, Maxwell Herbert, Molly Hemenway
The incidence and characterization of weight gain associated with MEK inhibitors in pediatric patients. Pediatric blood & cancer 70 (4) (2023)
Cassandra Rush, Ashley Sabus, Zanette Kanani Bradley, Maxwell Herbert, Molly Hemenway
The incidence and characterization of weight gain associated with MEK inhibitors in pediatric patients. Pediatric blood & cancer 70 (4) (2023)
Priya P Chan, Ashley Sabus, Molly S Hemenway, Kathryn C Chatfield, Christina J White, David M Mirsky, Nicholas K Foreman, Nathan A Dahl
Thromboembolic toxicity observed with concurrent trametinib and lenalidomide therapy. Pediatric blood & cancer 70 (3) (2023)
Priya P Chan, Ashley Sabus, Molly S Hemenway, Kathryn C Chatfield, Christina J White, David M Mirsky, Nicholas K Foreman, Nathan A Dahl
Thromboembolic toxicity observed with concurrent trametinib and lenalidomide therapy. Pediatric blood & cancer 70 (3) (2023)
Bradley P Dixon, Ashley Sabus
Ravulizumab 100 mg/mL formulation reduces infusion time and frequency, improving the patient and caregiver experience in the treatment of atypical haemolytic uraemic syndrome. Journal of clinical pharmacy and therapeutics 47 (7) (2022)